| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 01/24/2011 | 4:56PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/24/2011 | 4:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/24/2011 | 4:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/21/2011 | 6:05AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/21/2011 | 6:05AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/20/2011 | 9:25AM | PR Newswire (US) | Ardea Biosciences Prices Public Offering of Common Stock | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/19/2011 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/19/2011 | 4:15PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/19/2011 | 4:00PM | PR Newswire (US) | Ardea Biosciences Announces Proposed Public Offering of Common Stock | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/10/2011 | 8:16AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/10/2011 | 8:00AM | PR Newswire (US) | Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/06/2011 | 4:18PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/06/2011 | 4:00PM | PR Newswire (US) | Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/05/2011 | 4:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/05/2011 | 4:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/05/2011 | 4:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 01/05/2011 | 4:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/30/2010 | 8:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/21/2010 | 6:01AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/16/2010 | 7:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/16/2010 | 7:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/16/2010 | 7:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/16/2010 | 7:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/10/2010 | 9:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/30/2010 | 1:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/22/2010 | 7:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/18/2010 | 6:08AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/17/2010 | 5:12PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/16/2010 | 6:00AM | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |